Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)
A Single Center Open Label Early Feasibility Study to Evaluate the Efficacy and Safety of the RenewalNail™ Plasma Treatment System in Patients With Mild to Moderate Onychomycosis (Fungal Nail) of the Hallux Caused by Trichophyton Rubrum or Trichophyton Mentagrophytes.
Sponsor: DeviceFarm, Inc.
Listed as NCT03216200, this NA trial focuses on Onychomycosis and Onychomycosis of Toenail and remains completed. Sponsored by DeviceFarm, Inc., it has been updated 12 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Nov 2019 — Feb 2020 [monthly]
Completed NA
-
Mar 2019 — Nov 2019 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Aug 2018 — Mar 2019 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting NA
-
Nov 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Aug 2017 — Nov 2017 [monthly]
Recruiting NA
First recorded
Jul 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- DeviceFarm, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .